Clinical Trial Update: A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing long-term immunogenicity and booster response of Purified Chick-Embryo Cell Rabies Vaccine in adults after primary pre-exposure…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• Purified Chick-Embryo Cell Rabies Vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Virus Diseases, Rabies | Phase 3 | Status: COMPLETED | Results posted: 2024-07-18